NEW DIAGNOSTICS. “Clock genes showed significant difference for distinct patient subtypes within a cancer type, and may serve as promising biomarkers. Our results highlight the possible clinical utility of clock genes in human cancer.”
https://lnkd.in/dT2NKaY
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022